Question: how are donor specific antibodies measured?
Answer: The use of cPRA as a measure of predicting the percent of potential donors against whom a patient may have antibodies have significantly improved organ allocation. cPRA is calculated based on the frequency of different HLA phenotypes, or combinations of HLA phenotypes that are incompatible with the patient.